INTRODUCTION
Although experience of anticoagulation treatment after mechanical prosthetic valve replacement has accumulated, the proper level of anticoagulation remains controversial.
Over-dosage of Coumadin, which is an oral anticoagulant, can result in bleeding and under-dosage can bring on the complication of a thromboembolic event, so it is very im- [2] [3] [4] [5] . There are ethnic differences in response to anticoagulation therapy, so a lower INR has been suggested for Asian than for Westerners [6] [7] [8] [9] . The authors have also reported an adequacy of INR ranging from 1.5 to 2.5 [10] . In order to prevent thromboembolic events, the good compliance of patients is essential [4] . In this study, the patients lived near the hospital, so we checked the patient's INR at intervals of 4 to 8 weeks. We reviewed the relationship between thromboembolic events and the mean INR and INR measurement interval in patients who had undergone mechanical prosthetic aortic valve replacements and maintained the level of INR from 1.5 to 2.5. We present the cumulative variables as mean and standard deviation, and the linearized occurrence rate as %/patient-year. We used Kaplan-Meier analysis for the long-term results of thromboembolism and distinguished the differences between the groups with the Student's t-test. We regarded the value of p＜0.05 as significant.
MATERIALS AND METHODS

RESULTS
The median age at surgery was 53 years old (16 to 72). (Fig. 1) .
We compared the rate of target maintenance between the thromboembolism event group (N=10) and the normal group (N=52) without complications related to anticoagulation. The INR of all patients varied within the range of 0.9 to 11.97.
We targeted an INR range from 1.5 to 2.5. There was no significant difference in the mean maintenance rate between the normal group (N=52) and the thromboembolic event group (N=10), which was 59.12±11.80%, 58.11±13.21% in each group, respectively (p=0.40) ( Table 1 ).
The mean INR was 1.86±0.14 in the normal group and 1.80±0.11 in the event group, and the difference between these two was not significant (p=0.367) ( days in the event group. Therefore, there was no significant difference between the two groups (p=0.14) ( Table 2) . However, when we observed the INR measurement interval during the 6 months right before events, the mean interval of the event group was 65.89±44.88 days. That was significantly longer than the mean interval of the normal group, which was 49.04±9.48 days (p＜0.01) ( Table 2) .
DISCUSSION
INR, which is a standardized measurement of anticoagulation, has been used widely since the recommendation by the WHO [11] . In addition, in order to prevent the patients who have mechanical valves from experiencing thromboembolism, the need for adequate warfarin anticoagulation showed low rate of bleeding and thromboembolic complications. The optimum low intensity anticoagulation therapy has been reported in Korea. Jeong et al. [5] reported that there was no statistically significant differences in thromboembolism occurrence in the groups with an INR of 1.5 to 2.0, 2.0 to 2.5, and 2.5 to 3.0, and the bleeding rate was higher in the group with high intensity anticoagulation therapy. Kim and Kim [4] suggested that a lower INR from 1.5 to 2.5 would be optimal for patients who have mechanical prosthetic aortic valves. The authors have reported an optimal level from 1.5 to 2.5 in a previous study [10] . In the present study, the target INR was set at 1.5 to 2.5 for the patients who had undergone isolated mechanical aortic valve replacement. We used various types of valves, but we did not believe that the analysis of individual valves would be meaningful [18] . There were no differences in the rate of target INR maintenance or in the mean INR between the groups regardless of valve type. We assessed the INR during the four months before complications occurred, and this value was significantly different between the two groups. The INR of the event group was 1.50 and was significantly lower than that of the normal group, which was 1.86. This means that a certain period of very low INR, rather than the usual maintenance of the mean INR level, can bring on thromboembolic events.
We analyzed the differences in INR measurement interval between the normal and the thromboembolic event groups.
We reviewed the 6 months just before the complications because there were no differences in the INR measurement interval of the two groups over the whole observational period.
The INR measurement interval of the normal group was 49 days and that of the event group was 66 days. The event group showed lower patient compliance with taking anticoagulants.
To maintain INR in the target range for the patients who take warfarin, regular examinations are essential. Lidstone et al. [19] claimed that in some selected patients, they could elongate the INR measurement interval to 14 weeks or more safely; however, we believe this elongated interval is not optimal because the INR measurement interval just before the complications was 66 days and longer than that of the normal group. In addition, the INR level was lower, despite the fact that exams were performed every 4 to 8 weeks in this study. Torella et al. [18] suggested that in the bi-leaflet mechanical aortic valve group, it would be safe to maintain a low intensity INR level from 1.5 to 2.5. Their mean INR was 
CONCLUSION
We suggest that to maintain an INR level over 1.8 and INR measurement interval of 7 to 8 weeks would be safe for preventing thromboembolic events when a low level of anti-
